Glucocerebrosidase mutations in a Serbian Parkinson's disease population

K. R. Kumar, A. Ramirez, A. Göbel, N. Kresojević, M. Svetel, K. Lohmann, C. M Sue, A. Rolfs, J. R. Mazzulli, R. N. Alcalay, D. Krainc, C. Klein*, V. Kostic, A. Grünewald

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Background and purpose: To screen for glucocerebrosidase (GBA) mutations in a Serbian Parkinson's disease (PD) population. Methods: Glucocerebrosidase exons 8-11 harbouring the most common mutations were sequenced in 360 patients with PD and 348 controls from Serbia. Haplotype analysis was performed for the N370S mutation and compared with German and Ashkenazi Jewish carriers. Results: Glucocerebrosidase mutations were significantly more frequent in patients with PD (21/360; 5.8%) vs. controls (5/348; 1.4%; OR = 4.25; CI, 1.58-11.40; P = 0.0041). Two patients with PD carried homozygous or compound heterozygous mutations in GBA. The N370S mutation accounted for about half of the mutated alleles in patients (10/23) but was absent amongst controls. Three novel variants were detected including two non-synonymous variants (D380V, N392S) in the patient group and one synonymous change (V459V) in a control. Carriers of the D409H mutation were also sequenced for H255Q, and all were found to carry the [D409H; H255Q] double-mutant allele. Genotyping suggested a common haplotype for all N370S carriers. Conclusion: Glucocerebrosidase mutations represent a PD risk factor in the Serbian population.

Original languageEnglish (US)
Pages (from-to)402-405
Number of pages4
JournalEuropean Journal of Neurology
Issue number2
StatePublished - Feb 2013


  • GBA
  • Gaucher disease
  • Glucocerebrosidase
  • Parkinson's disease
  • Serbian

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Glucocerebrosidase mutations in a Serbian Parkinson's disease population'. Together they form a unique fingerprint.

Cite this